VEMAX | VEMRX | VEMAX / VEMRX | |
Total Expense Ratio | 0.13 | 0.07 | 186% |
Annual Report Gross Expense Ratio | 0.13 | 0.07 | 186% |
Fund Existence | 19 years | 15 years | - |
Gain YTD | 21.144 | 21.183 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 100000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 130B | 130B | 100% |
Annual Yield % from dividends | 2.65 | 2.70 | 98% |
Returns for 1 year | 13.70 | 13.75 | 100% |
Returns for 3 years | 53.21 | 53.42 | 100% |
Returns for 5 years | 38.74 | 39.03 | 99% |
Returns for 10 years | 93.76 | 94.31 | 99% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.67 | 0.37 | +1.35% |
First Trust Nasdaq Pharmaceuticals ETF | |||
RSPG | 81.56 | 0.99 | +1.23% |
Invesco S&P 500® Equal Weight Energy ETF | |||
GSUS | 91.83 | 0.53 | +0.58% |
Goldman Sachs MarketBeta US Equity ETF | |||
EVIM | 52.51 | 0.02 | +0.03% |
Eaton Vance Intermediate Muncpl Inc ETF | |||
EBIT | 33.93 | N/A | N/A |
Harbor AlphaEdge Small Cap Earners ETF |